About this trial
This single-center, open, non-randomized study aims the efficacy evaluation of Effaclar Duo+M and Effaclar+M Purifying foaming gel on total acne lesion count, pigmented lesions and scars for 6 months in subjects with mild to moderate facial and truncal acne.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
phototype I to VI
mild to moderate acne on the face and trunk
Disqualifiers
cutaneous pathology on the studied zone other than acne
topical or systemic treatment during the previous weeks liable to interfere with the assessment of the acceptability and efficacy of the studied products
Trial design
Single group
Treatments tested in this trial
acneic participants group
Other interventionApplication of Effaclar Duo+M to the face and trunk twice daily (morning and evening) after washing with the cleansing gel.
Treatment groups
Trial outcomes
Primary outcomes
efficacy on total acne lesion count on face and trunk
The counting is performed by region (back, chest, face, total) and type of lesion (post-inflammatory hyperpigmentation, post-inflammatory erythema, scars, pustules, nodules, papules, closed comedones, open comedones.
Secondary outcomes
Evaluation of the degree of severity of acne on the face
Evaluation performed thanks to the Global Evaluation Acne (GEA) scale on a 6-point score: from 0 (Clean. No lesions) to 5 (Very severe).
Evaluation of the degree of severity of acne on the trunk
Evaluation performed thanks to the Investigator Global Assessment (IGA) scale on a 6-point score: from 0 (Absent) to 5 (Very serious).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.